<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940104-2-00064</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> January 4, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> <!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Drug Enforcement Administration</USBUREAU> <!-- PJG /ITAG -->  <!-- PJG ITAG l=56 g=1 f=1 -->  <DOCTITLE>Controlled Substances; Established 1993 Aggregate Production Quotas</DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Drug Enforcement Administration, Justice. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Final rule establishing 1993 aggregate production quotas. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> The interim rule (58 FR 51382, October 1, 1993) which established 1993 revised aggregate production quotas for some controlled substances in Schedules I and II, as required under the Controlled Substances Act (CSA) (21 U.S.C. 826) is adopted without change. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </SUMMARY> <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> January 4, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </DATE> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Howard McClain, Jr., Chief, Drug &amp; Chemical Evaluation Section, Drug Enforcement Administration, Washington, DC 20537, telephone: (202) 307&hyph;7183. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </FURTHER> <SUPPLEM> <!-- PJG ITAG l=10 g=1 f=2 --> SUPPLEMENTARY INFORMATION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Section 306 of the Controlled Substances Act, (21 U.S.C. 826), requires the Attorney General to establish aggregate production quotas for controlled substances in Schedules I and II each year. This responsibility has been delegated to the Administrator of the Drug Enforcement Administration pursuant to &sect;0.100 of title 28 of the Code of Federal Regulations. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> On October 1, 1993, an interim rule establishing revised 1993 aggregate production quotas for controlled substances in Schedules I and II was published in the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal Register  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (58 FR 51382). One comment was received from a company supporting the use of the interim rule in establishing aggregate production quotas under certain circumstances. The interim rule is adopted without change. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> This rule is not a significant regulatory action and therefore has not been reviewed by the Office of Management and Budget pursuant to Executive Order 12866. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> These actions have been analyzed in accordance with the principles and criteria contained in Executive Order 12612, and it has been determined that this matter does not have sufficient federalism implications to warrant the preparation of a Federalism Assessment. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> The Administrator hereby certifies that this action will have no significant impact upon small entities whose interests must be considered under the Regulatory Flexibility Act, 5 U.S.C. 601, et seq. The establishment of annual aggregate production quotas for Schedules I and II controlled substances is mandated by law and by international commitments of the United States. Such quotas impact predominantly upon major manufacturers of the affected controlled substance. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Therefore, under the authority vested in the Attorney General by section 306 of the CSA of 1970 (21 U.S.C. 826) and delegated to the Administrator by &sect;0.100 of title 28 of the Code of Federal Regulations, the Administrator of the DEA hereby establishes the following revised 1993 aggregate production quotas for the listed controlled substances, expressed in grams of anhydrous base: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 2,L2,tp0,i1,s80,11 -->  <!-- PJG ITAG l=95 g=1 f=1 --> &blank; <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Basic class  <!-- PJG 007 0150 intable --> 1Established 1993 quotas (in grams) <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 --> Schedule I: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=02 g=1 f=2 --> Methaqualone  <!-- PJG 007 0104 intable --> 12 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3,4-Methylenedioxyamphetamine  <!-- PJG 007 0104 intable --> 12 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3,4-Methylenedioxymethamphetamine  <!-- PJG 007 0104 intable --> 12 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=2 --> Schedule II: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=02 g=1 f=2 --> Dextropropoxyphene  <!-- PJG 007 0104 intable --> 115,162,000 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Methadone (for sale)  <!-- PJG 007 0104 intable --> 3,675,000 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Methadone Intermediate (for conv)  <!-- PJG 007 0104 intable --> 4,598,000 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Oxycodone (for sale)  <!-- PJG 007 0104 intable --> 3,520,000 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Phencyclidine  <!-- PJG 007 0104 intable --> 54 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Thebaine  <!-- PJG 007 0104 intable --> 7,795,000 <!-- PJG /ITAG -->  </TABLE>  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=2 --> Dated: December 22, 1993. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <SIGNER> <!-- PJG ITAG l=06 g=1 f=2 --> Stephen H. Greene, <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=2 --> Acting Administrator of Drug Enforcement. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=2 --> [FR Doc. 94&hyph;108 Filed 1&hyph;3&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=2 --> BILLING CODE 4410&hyph;09&hyph;M <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            